申请人:Schering Aktiengesellschaft
公开号:US05414002A1
公开(公告)日:1995-05-09
5- or 6-substituted .beta.-carboline-3-carboxylic acid esters of Formula I ##STR1## wherein R.sup.1 is hydrogen, nitrilo, halogen, lower alkyl or lower alkoxy, and R.sup.3 is a branched C.sub.3-6 alkyl group which is optionally substituted by halogen, or a C.sub.3-6 cycloalkyl group which is optionally methyl-substituted, are valuable pharmaceuticals.
公式I中的5-或6-取代的β-喹啉-3-羧酸酯化合物,其中R1是氢、亚硝基、卤素、低碳基或低碳氧基,而R3是分支的C3-6烷基,可选地被卤素取代,或是C3-6环烷基,可选地被甲基取代,是有价值的药物。